SIRT3 deacetylates and promotes degradation of P53 in PTEN-defective non-small cell lung cancer Yanlu XiongLei WangYong Han Original Article – Cancer Research 04 November 2017 Pages: 189 - 198
Preferential expression of NY-BR-1 and GATA-3 in male breast cancer Giovanni Battista BiserniEnrico Di OtoZsuzsanna Varga Original Article – Cancer Research Open access 07 November 2017 Pages: 199 - 204
Knockdown of LncRNA ANRIL suppresses cell proliferation, metastasis, and invasion via regulating miR-122-5p expression in hepatocellular carcinoma Ji MaTengfei LiHuifeng Yuan Original Article – Cancer Research 10 November 2017 Pages: 205 - 214
Epigenetic silencing of ADAMTS5 is associated with increased invasiveness and poor survival in patients with colorectal cancer Jizhen LiYi LiaoZuli Yang Original Article – Cancer Research 15 November 2017 Pages: 215 - 227
The risk of lung cancer among cooking adults: a meta-analysis of 23 observational studies Peng-Li JiaChao ZhangXin Sun Original Article – Cancer Research 21 November 2017 Pages: 229 - 240
Expression profile of microRNA-146a along HPV-induced multistep carcinogenesis: a study in HPV16 transgenic mice Rita AraújoJoana M. O. SantosRui M. Gil da Costa Original Article – Cancer Research 27 November 2017 Pages: 241 - 248
Induction of apoptosis in breast cancer cells in vitro by Fas ligand reverse signaling Thomas KolbenUdo JeschkeTheresa M. Kolben Original Article – Cancer Research 28 November 2017 Pages: 249 - 256
Analysis of TSC1 mutation spectrum in mucosal melanoma Meng MaJie DaiJun Guo Original Article – Cancer Research 28 November 2017 Pages: 257 - 267
The NF-κB signalling pathway in colorectal cancer: associations between dysregulated gene and miRNA expression Martha L. SlatteryLila E. MullanyJennifer S. Herrick Original Article – Cancer Research Open access 29 November 2017 Pages: 269 - 283
Effects of nutraceuticals on anaplastic thyroid cancer cells Lorenzo AllegriFrancesca RosignoloGiuseppe Damante Original Article – Cancer Research 02 December 2017 Pages: 285 - 294
The function of BTG3 in colorectal cancer cells and its possible signaling pathway Chi LvHeling WangQi Su Original Article – Cancer Research Open access 21 December 2017 Pages: 295 - 308
Identification of genes highly downregulated in pancreatic cancer through a meta-analysis of microarray datasets: implications for discovery of novel tumor-suppressor genes and therapeutic targets Nalin C. W. GoonesekereWyatt AndersenXiaosheng Wang Original Article – Cancer Research 29 December 2017 Pages: 309 - 320
Exploratory analyses assessing the impact of early tumour shrinkage and depth of response on survival outcomes in patients with RAS wild-type metastatic colorectal cancer receiving treatment in three randomised panitumumab trials Julien TaiebFernando RiveraMarc Peeters Original Article – Clinical Oncology Open access 28 October 2017 Pages: 321 - 335
Survival benefit of tamoxifen and aromatase inhibitor in male and female breast cancer Holm EggemannUdo AltmannAtanas Ignatov Original Article – Clinical Oncology 02 November 2017 Pages: 337 - 341
Model-based optimization of G-CSF treatment during cytotoxic chemotherapy Sibylle SchirmChristoph EngelMarkus Scholz Original Article – Clinical Oncology Open access 04 November 2017 Pages: 343 - 358
Early recurrence in patients undergoing curative resection of colorectal liver oligometastases: identification of its clinical characteristics, risk factors, and prognosis Junzhong LinJianhong PengZhizhong Pan Original Article – Clinical Oncology Open access 11 November 2017 Pages: 359 - 369
Head and neck rhabdomyosarcoma in children: a 20-year retrospective study at a tertiary referral center Sophia Marie HäußlerCarmen StrombergerArne Böttcher Original Article – Clinical Oncology 16 November 2017 Pages: 371 - 379
A comparison of tumour size measurements with palpation, ultrasound and mammography in male breast cancer: first results of the prospective register study Martin StrengAtanas IgnatovHolm Eggemann Original Article – Clinical Oncology 04 December 2017 Pages: 381 - 387
Taxane, platinum and 5-FU prior to chemoradiotherapy benefits patients with stage IV neck node-positive head and neck cancer and a good performance status Natalie M. LoweJonathan M. BernsteinNicholas J. Slevin Original Article – Clinical Oncology 08 December 2017 Pages: 389 - 401
Metronomic capecitabine as second-line treatment for hepatocellular carcinoma after sorafenib discontinuation Franco TrevisaniGiovanni BrandiGiovan Giuseppe Di Costanzo Original Article – Clinical Oncology 16 December 2017 Pages: 403 - 414
